Mutations in pfmdr1 modulate the sensitivity of Plasmodium falciparum to the intrinsic antiplasmodial activity of verapamil

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 840-842

  Hayward, Rhys ^a   Saliba, Kevin J ^a   Kirk, Kiaran ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ARTICLE; DNA POLYMORPHISM; DRUG ACTIVITY; DRUG EFFECT; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; NONHUMAN; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; ANTIMALARIALS; CALCIUM CHANNEL BLOCKERS; CHLOROQUINE; DRUG RESISTANCE; MUTATION; P-GLYCOPROTEIN; PLASMODIUM FALCIPARUM; VERAPAMIL;

EID: 12944300985     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.840-842.2005     Document Type: Article

References (27)

1. Adovelande, J., J. Deleze, and J. Schrevel. 1998. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum. Biochem. Pharmacol. 55:433-440.
2. Bray, P. G., M. Mungthin, R. G. Ridley, and S. A. Ward. 1998. Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. 54:170-179.
3. Cowman, A. F., D. Galatis, and J. K. Thompson. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA 91:1143-1147.
4. Cowman, A. F., S. Karcz, D. Galatis, and J. G. Culvenor. 1991. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 113:1033-1042.
5. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
6. Desneves, J., G. Thorn, A. Berman, D. Galatis, N. La Greca, J. Sinding, M. Foley, L. W. Deady, A. F. Cowman, and L. Tilley. 1996. Photoaffinity labeling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 82:181-194.
7. Ferdig, M. T., R. A. Cooper, J. Mu, B. Deng, D. A. Joy, X. Z. Su, and T. E. Wellems. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52:985-997.
8. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
9. Johnson, D. J., D. A. Fidock, M. Mungthin, V. Lakshmanan, A. B. Sidhu, P. G. Bray, and S. A. Ward. 2004. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15:867-877.
10. Karcz, S. R., D. Galatis, and A. F. Cowman. 1993. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. Mol. Biochem. Parasitol. 58:269-276.
11. Klokouzas, A., S. Shahi, S. B. Hladky, M. A. Barrand, and H. W. van Veen. 2003. ABC transporters and drug resistance in parasitic protozoa. Int. J. Antimicrob. Agents 22:301-317.
12. Kyle, D. E., A. M. Oduola, S. K. Martin, and W. K. Milhous. 1990. Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans. R. Soc. Trop. Med. Hyg. 84:474-478.
13. Martin, R. E., and K. Kirk. 2004. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol. Biol. Evol. 21:1938-1949.
14. Martin, S. K., A. M. Oduola, and W. K. Milhous. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
15. Martiney, J. A., A. Cerami, and A. F. Slater. 1995. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. 270:22393-22398.
16. +-ATPase of Streptococcus pneumoniae. Antimictob. Agents Chemother. 46:1680-1687.
17. Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 98:12689-12694.
18. Mungthin, M., P. G. Bray, R. G. Ridley, and S. A. Ward. 1998. Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob. Agents Chemother. 42:2973-2977.
19. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
20. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
21. Riffkin, C. D., R. Chung, D. M. Wall, J. R. Zalcberg, A. F. Cowman, M. Foley, and L. Tilley. 1996. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem. Pharmacol. 52:1545-1552.
22. Rubio, J. P., and A. F. Cowman. 1996. The ATP-binding cassette (ABC) gene family of Plasmodium falciparum. Parasitol. Today 12:135-140.
23. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
24. Sullivan, D. J., Jr., H. Matile, R. G. Ridley, and D. E. Goldberg. 1998. A common mechanism for blockade of heme polymerization by antimalarial quinolines. J. Biol. Chem. 273:31103-31107.
25. Tran, C. V., and M. H. Saier, Jr. 2004. The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 150:1-3.
26. van Schalkwyk, D. A., J. C. Walden, and P. J. Smith. 2001. Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers. Antimicrob. Agents Chemother. 45:3171-3174.
27. Warhurst, D. C., J. C. Craig, I. S. Adagu, D. J. Meyer, and S. Y. Lee. 2003. The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malar. J. 2:26.